Treasurer of the State of North Carolina’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.1M Buy
68,726
+19,968
+41% +$10.5M 0.12% 169
2025
Q1
$30.9M Sell
48,758
-9,365
-16% -$5.94M 0.12% 157
2024
Q4
$41.4M Sell
58,123
-490
-0.8% -$349K 0.16% 104
2024
Q3
$61.6M Sell
58,613
-494
-0.8% -$519K 0.25% 69
2024
Q2
$62.1M Buy
59,107
+1,541
+3% +$1.62M 0.26% 64
2024
Q1
$55.4M Sell
57,566
-1,042
-2% -$1M 0.24% 79
2023
Q4
$51.5M Buy
58,608
+230
+0.4% +$202K 0.25% 79
2023
Q3
$48M Sell
58,378
-590
-1% -$486K 0.26% 72
2023
Q2
$42.4M Sell
58,968
-399
-0.7% -$287K 0.22% 87
2023
Q1
$48.8M Buy
59,367
+387
+0.7% +$318K 0.28% 73
2022
Q4
$42.6M Buy
58,980
+3,850
+7% +$2.78M 0.26% 82
2022
Q3
$38M Buy
55,130
+959
+2% +$661K 0.25% 78
2022
Q2
$32M Buy
54,171
+2,249
+4% +$1.33M 0.2% 99
2022
Q1
$36.3M Buy
51,922
+1,900
+4% +$1.33M 0.2% 99
2021
Q4
$31.6M Buy
50,022
+876
+2% +$553K 0.17% 118
2021
Q3
$29.7M Buy
49,146
+927
+2% +$561K 0.17% 119
2021
Q2
$26.9M Buy
48,219
+2,136
+5% +$1.19M 0.16% 137
2021
Q1
$21.8M Buy
46,083
+806
+2% +$381K 0.14% 147
2020
Q4
$21.9M Buy
45,277
+540
+1% +$261K 0.15% 141
2020
Q3
$25M Buy
44,737
+1,255
+3% +$703K 0.19% 109
2020
Q2
$27.1M Buy
43,482
+2,857
+7% +$1.78M 0.22% 90
2020
Q1
$19.8M Buy
40,625
+2,843
+8% +$1.39M 0.18% 121
2019
Q4
$14.2M Buy
37,782
+360
+1% +$135K 0.12% 180
2019
Q3
$10.4M Sell
37,422
-14,987
-29% -$4.16M 0.09% 201
2019
Q2
$16.4M Buy
52,409
+720
+1% +$225K 0.1% 192
2019
Q1
$21.2M Buy
51,689
+1,310
+3% +$538K 0.14% 162
2018
Q4
$18.8M Buy
50,379
+548
+1% +$205K 0.14% 160
2018
Q3
$20.1M Buy
49,831
+17,045
+52% +$6.89M 0.13% 172
2018
Q2
$11.3M Buy
32,786
+20,521
+167% +$7.08M 0.12% 179
2018
Q1
$4.22M Buy
+12,265
New +$4.22M 0.11% 201